Bruker and Bruker Revenues Up Though Customers Delay Mass Spec Buys
Bruker Biosciences, born from the merger of Bruker Daltonics and Bruker AXS on July 1, reported increased second-quarter revenues for both of its component companies this week.
Bruker and Bruker Revenues Up Though Customers Delay Mass Spec Buys
Bruker Biosciences, born from the merger of Bruker Daltonics and Bruker AXS on July 1, reported increased second-quarter revenues for both of its component companies this week.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.